Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AssayQuant Technologies develops and commercializes innovative fluorescence-based assay technologies that enable real-time, quantitative measurement of kinase and phosphatase activity. Their flagship PhosphoSens® platform supports high-throughput screening, profiling, and kinetic analysis for over 500 enzyme targets. The company’s solutions accelerate drug discovery by providing richer data than traditional endpoint assays. They have received SBIR funding to expand their technology into more complex sample types such as cell lysates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AssayQuant Technologies.